Basic Information
| LncRNA/CircRNA Name | lncRNA-ATB |
| Synonyms | LOC109207222 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | papillary thyroid cancer |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot |
| Sample | papillary thyroid carcinoma tissues, blood, cell lines (IHH-4, HTH83) |
| Expression Pattern | up-regulated |
| Function Description | lncRNA-ATB expression level was higher in tumor tissues than in adjacent healthy tissues in most PTC patients.Serum lncRNA-ATB can be used to accurately predict PTC and its prognosis. lncRNA-ATB overexpression promoted tumor cell migration and invasion. |
| Pubmed ID | 30042377 |
| Year | 2018 |
| Title | Upregulation of lncRNA-ATB by Transforming Growth Factor ?1 (TGF-?1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells. |
External Links
| Links for lncRNA-ATB | GenBank HGNC NONCODE |
| Links for papillary thyroid cancer | OMIM COSMIC |